This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hegele, R. A. Articles by Hramiak, I. M. Search for Related Content PubMed PubMed Citation Articles by Hegele, R. A. Articles by Hramiak, I. M.

Heterogeneity of Nuclear Lamin A Mutations in Dunnigan-Type Familial Partial Lipodystrophy¹

Robarts Research Institute and Department of Medicine, University of Western Ontario, London, Ontario, Canada N6A 5K8

Address all correspondence and requests for reprints to: Robert A. Hegele, M.D., Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406–100 Perth Drive, London, Ontario, Canada N6A 5K8. E-mail: robert.hegele{at}rri.on.ca

We previously identified a novel mutation, namely LMNA R482Q, that was found to underlie Dunnigan-type partial lipodystrophy (FPLD) and diabetes in an extended Canadian kindred. We have since sequenced LMNA in five additional Canadian FPLD probands and herein report three new rare missense mutations in LMNA: V440M, R482W, and R584H. One severely affected subject was a compound heterozygote for both V440M and R482Q. The findings indicated that 1) a spectrum of LMNA mutations underlies FPLD; 2) aberrant lamin A, and not lamin C, is likely to underlie FPLD, as R584H occurs within LMNA sequence that is specific for lamin A; 3) the V440M mutation may not cause lipodystrophy on its own; 4) compound heterozygosity for V440M and R482Q is associated with a relatively more severe FPLD phenotype, but not with complete lipodystrophy; and 5) variation in the severity of the phenotype might be related to environmental factors.

This article has been cited by other articles:

				F. Lombardi, F. Gullotta, M. Columbaro, A. Filareto, M. D'Adamo, A. Vielle, V. Guglielmi, A. M. Nardone, V. Azzolini, E. Grosso, et al. Compound Heterozygosity for Mutations in LMNA in a Patient with a Myopathic and Lipodystrophic Mandibuloacral Dysplasia Type A Phenotype J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4467 - 4471. [Abstract] [Full Text] [PDF]

				R. A. Hegele, T. R. Joy, S. A. Al-Attar, and B. K. Rutt Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism J. Lipid Res., July 1, 2007; 48(7): 1433 - 1444. [Abstract] [Full Text] [PDF]

				R. Cortese, F. Eckhardt, M. Volleth, M. Wehnert, U. Koelsch, P. Wieacker, and T. Brune The retinol acid receptor B gene is hypermethylated in patients with familial partial lipodystrophy J. Mol. Endocrinol., June 1, 2007; 38(6): 663 - 671. [Abstract] [Full Text] [PDF]

				H. Van Esch, A. K. Agarwal, P. Debeer, J.-P. Fryns, and A. Garg A Homozygous Mutation in the Lamin A/C Gene Associated with a Novel Syndrome of Arthropathy, Tendinous Calcinosis, and Progeroid Features J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 517 - 521. [Abstract] [Full Text] [PDF]

				K. N. Jacob, F. Baptista, H. G. dos Santos, J. Oshima, A. K. Agarwal, and A. Garg Phenotypic Heterogeneity in Body Fat Distribution in Patients with Atypical Werner's Syndrome Due to Heterozygous Arg133Leu Lamin A/C Mutation J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6699 - 6706. [Abstract] [Full Text] [PDF]

				L. C. Mounkes, S. V. Kozlov, J. N. Rottman, and C. L. Stewart Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice Hum. Mol. Genet., August 1, 2005; 14(15): 2167 - 2180. [Abstract] [Full Text] [PDF]

				I. K. Aronson and V. C. Fiedler Of Mice and Men: The Road to Understanding the Complex Nature of Adipose Tissue and Lipoatrophy Arch Dermatol, January 1, 2003; 139(1): 81 - 83. [Full Text] [PDF]

				R. A. Hegele, M. E. Kraw, M. R. Ban, B. A. Miskie, M. W. Huff, and H. Cao Elevated Serum C-Reactive Protein and Free Fatty Acids Among Nondiabetic Carriers of Missense Mutations in the Gene Encoding Lamin A/C (LMNA) With Partial Lipodystrophy Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 111 - 116. [Abstract] [Full Text] [PDF]

				K. Heathcote, A. Rajab, J. Magre, P. Syrris, M. Besti, M. Patton, M. Delepine, M. Lathrop, J. Capeau, and S. Jeffery Molecular Analysis of Berardinelli-Seip Congenital Lipodystrophy in Oman: Evidence for Multiple Loci Diabetes, April 1, 2002; 51(4): 1291 - 1293. [Abstract] [Full Text] [PDF]

				R. D. Goldman, Y. Gruenbaum, R. D. Moir, D. K. Shumaker, and T. P. Spann Nuclear lamins: building blocks of nuclear architecture Genes & Dev., March 1, 2002; 16(5): 533 - 547. [Full Text] [PDF]

				H. H.-J. Schmidt and R. A. Hegele Consider Cardiomyopathy in Subjects With Familial Partial Lipodystrophy Response Circulation, January 15, 2002; 105 (2): e7 - e7. [Full Text] [PDF]

				R. A. Hegele Premature Atherosclerosis Associated With Monogenic Insulin Resistance Circulation, May 8, 2001; 103(18): 2225 - 2229. [Abstract] [Full Text] [PDF]